#BrainDrugsEpilepsy is a #precision medicine project aiming at identifying factors that determine the early cause of epilepsy to improve individual patient care
1/ We tweet for health care professionals, patients and relatives on new initiatives and results in #precision medicine in #epilepsy with special reference to #BrainDrugs – a strategic research alliance funded by the #LundbeckFoundation and anchored at #Rigshospitalet in Denmark.
Læs denne fine journalistiske artikel fra UfL i denne uge! Hvordan kan vi ændre det?
Fri adgang til forskning er guld værd – for forlagene https://t.co/JhKYBTzq7v
Epilepsy and brain network hubs https://t.co/oe0QKnYSj2
Interesting review by key persons in the field on brain network organization and dynamics using EEG and MRI. Highly relevant to BrainDrugs - and our understanding of morbidity and prognostics in the early course of epilepsy
'm happy to be part of the 35th ECNP Congress, 15-18 October! Join my session on ‘ S05 – Is epilepsy a psychiatric disorder? ’ in-person in Vienna or online!
You can find more info and register via https://t.co/ej2k1bWaIY.
#ECNP2022#ECNPCongress#NeuroscienceApplied
Interesting study showing evidence of widespread abnormalities in WM diffusion metrics in patients with TLE-HS compared to FCD in the temporal or frontal lobe! It adds to our understanding of why cognitive and psychiatric dysfunction are seen so frequently in TLE-HS.
Tomorrow morning 8:30 @LarsPinborgEpi will introduce #BrainDrugs at the Department of Neurology at BBB. It will be truly excellent to have BBH @regionh join #BrainDrugsEpi and help recruit epilepsy patients for the study!
Marco Mula is the new EIC of Epilepsy & Behavior. @marco_mula is instrumental to the study of psychiatry in epilepsy both in science and in #ILAE, and a great inspiration to what we hope to achieve with #BrainDrugs. Congratulations!
@CopenhagenNeuro https://t.co/Mp4lSKwTWt <-- link to paper, please note the citations in the webpage got jumbled by the editorial team and we are working to fix it
In #BrainDrugs we explore the use of HD-EEG (@MagStimEGI) in collaboration with @SBeniczky as a potential early biomarker of drug-resistance and development of co-morbidity
[high-density EEG recording] Györfi et al.: "Measuring EEG electrode positions in high-density array, using the optical scanner is suitable for clinical implementation in EEG source imaging for presurgical evaluation."
https://t.co/NOyF05SHUf
@AUHdk
3/ In 2022, inclusion of first-seizure and newly diagnosed drug-naïve epilepsy patients aged 16-55 began. We will longitudinally collect a variety of biomarkers and potential risk/protective factors. Major outcome measures: QoL, seizure burden, psychiatric and cognitive function
1/ We tweet for health care professionals, patients and relatives on new initiatives and results in #precision medicine in #epilepsy with special reference to #BrainDrugs – a strategic research alliance funded by the #LundbeckFoundation and anchored at #Rigshospitalet in Denmark.
2/ We aim at identifying factors that cause, modify and label the early cause of epilepsy in individual patients and thereby will allow us to design better treatment and preventive strategies than the commonly used one-size-fits-all approach designed for average epilepsy patients